8-K ·Filed Jul 2, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
This is a routine director resignation with no financial or strategic implications. No trading action warranted.
Final — all horizons settled through T+60d
LENZ ▼ -34.47% at T+60d
NEUTRAL call -34.47% · α vs SPY -36.18% · entry $5.89 → $3.86
T+1d
-4.92%
call -4.92% · α -5.80%
$5.60
settled 4mo ago
T+5d
-1.70%
call -1.70% · α -2.63%
$5.79
settled 4mo ago
T+20d
-2.21%
call -2.21% · α -1.79%
$5.76
settled 3mo ago
T+60d
-34.47%
call -34.47% · α -36.18%
$3.86
settled 29d ago
Price Chart
Loading chart...
Executive Summary
Director Zach Scheiner resigned from the LENZ Therapeutics board effective June 30, 2026, with no dispute or disagreement regarding company operations. The board was reduced to six members, and Jeff George was appointed to the audit committee.
Key Facts
- Zach Scheiner resigned from the Board of Directors and all committees, effective June 30, 2026
- Resignation was not due to any dispute or disagreement with the company
- Board size decreased from 7 to 6 members
- Jeff George appointed to the Audit Committee, joining Shelley Thunen and Frederic Guerard
Financial Impact
No financial impact from this routine board change
Risk Factors
- No material risks identified from this filing
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
85% bullish (13 analysts)
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001815776-26-000046 |
| Document: 0001815776-26-000046-index-headers.html | 0001815776-26-000046 |
| Document: 0001815776-26-000046-index.html | 0001815776-26-000046 |
| Document: 0001815776-26-000046.txt | 0001815776-26-000046 |
10 reports for LENZ
67% Hit rate @ T+1 Went positive at some point 2 of 3 best @ T+1▲ +4.15%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | Press Release | $3.25 | awaiting T+1 | — | $3.14 (−3.23%) |
Oct 21, 2026 5d ago | SC 13G/A | $3.25 $3.16 | ▼ −2.77% | ▼ −2.25% | $3.14 (−3.23%) |
Aug 11, 2026 10w ago | Press Release | $5.04 $4.60 | ▼ −8.73% | ▼ −9.43% | $3.14 (−37.60%) |
Jul 2, 2026 16w ago | 8-K | $5.89 $5.60 | ▼ −4.92% | ▼ −5.80% | $3.14 (−46.60%) |
Jun 11, 2026 19w ago | Institutional Cluster | $6.50 $6.77 | ▲ +4.15% | ▲ +3.61% | $3.14 (−51.62%) |
Jun 7, 2026 20w ago | Press Release | $6.72 $6.79 | ▲ +1.04% | ▲ +1.34% | $3.14 (−53.20%) |
May 11, 2026 24w ago | 8-K | $7.91 $7.91 | · 0.00% | ▼ −0.54% | $3.14 (−60.24%) |
May 4, 2026 25w ago | Press Release | $9.28 $9.07 | ▼ −2.26% | ▼ −3.06% | $3.14 (−66.11%) |
Mar 24, 2026 30w ago | Press Release | $9.03 $9.07 | ▲ +0.44% | ▼ −0.12% | $3.14 (−65.17%) |
Feb 28, 2026 34w ago | Institutional Cluster | $13.68 $13.15 | ▼ −3.87% | ▼ −2.96% | $3.14 (−77.01%) |
Showing 10 of 10
US Market Status
Market Closed — Opens in 6h 15m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers